by PEPID Newsroom | Dec 3, 2018 | Press & Media
Phoenix, AZ, USA, December 3, 2018 — PEPID, LLC, trusted developer of top clinical decision support solutions, is eager to announce the latest additions to its ever-growing drug and clinical database. Beginning December 2018, subscribers on any platform can reference...
by Anna Tan | Nov 28, 2018 | Uncategorized
Healthcare reform and improvement has entered exciting times. Medical R&D and health informatics (HIT) are growing at a rapid rate, offering better options to a more curious and proactive generation of consumers. More regulatory bodies and forward-thinking...
by PEPID Newsroom | Nov 20, 2018 | Alerts
The FDA approved Aemcolo (rifamycin) yesterday for the treatment of travelers’ diarrhea. Aemcolo is an antibacterial drug to treat noninvasive strains of Escherichia coli (E. coli) not complicated by fever or blood in the stool. The FDA estimates 10-40% of travelers...
by Anna Tan | Nov 19, 2018 | Pharmacy
Today’s healthcare industry is a race between technology, policy, and support, with the endpoint for all of them being a more patient-centered approach. Technological advancements have made precision medicine possible, resulting in an explosion of data and inquiries...
by Anna Tan | Nov 14, 2018 | Pharmacy
Moving Forward with Proper PGx Expectations 2,5Pharmacogenomic (PGx) testing and PGx-based treatments may be all the rage in precision medicine today, but more genetic and pharmacology experts – especially in the areas of cardiology, pain management, and psychiatry –...
by PEPID Newsroom | Nov 14, 2018 | Alerts
FDA approves a new version of Primatene Mist, the only OTC metered-dose inhaler. Primatene Mist is approved by the FDA as an OTC drug to provide temporary relief for symptoms of mild, intermittent asthma. Primatene Mist is only approved for those who have been...
by Megan Pullins | Nov 14, 2018 | Alerts
Monday, JAMA published a summarized report of the just-released U.S. Department of Health and Human Services (HHS) second edition Physical Activity Guidelines for Americans (PAG), which provides evidence-based recommendations to improve American individual and...
by PEPID Newsroom | Nov 9, 2018 | Alerts
The FDA announced emergency use authorization for a rapid, single-use test to detect the Ebola Virus (Zaire ebolavirus). The test, called the DPP Ebola Antigen System (Chembio Diagnostic Systems Inc), is novel for using a portable battery reader for accurate...
by PEPID Newsroom | Nov 9, 2018 | Alerts
A French study finds an association between a higher frequency of organic food consumption and a reduced risk of cancer. The study findings still need to be confirmed. In this population-based cohort study of 68,947 French adults, high organic food scores were...
by Anna Tan | Nov 8, 2018 | Pharmacy
Moving Forward with Remote SupportThe intimidating costs behind patient-centered healthcare reform can be mitigated with the added revenue and reduced labor costs of establishing remote pharmacy models (RPMs). These highly efficient sites not only give operational...
